THUNDER BAY, Ontario--(BUSINESS WIRE)--Mitomics, world leader in research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today that it has added two seasoned executives to its leadership team. Luis Martin, Ph.D., has joined Mitomics as chief commercial officer, leading the company’s collaboration efforts for its Mitomic Test pipeline, while also managing the company’s regulatory affairs. Stephen S. Galliker, a highly experienced financial executive, has joined as a member of the Mitomics’ board of directors.
